We have located links that may give you full text access.
Journal Article
Multicenter Study
Maternal hepatitis B surface antigen carrier status and its impact on neonatal outcomes: a cohort study of 21 947 singleton newborns in China.
Journal of Maternal-fetal & Neonatal Medicine 2017 September
OBJECTIVE: To explore the impact of maternal hepatitis B surface antigen (HBsAg) carrier status on neonatal outcomes.
METHODS: A retrospective cohort study was conducted using data from medical records database of six hospitals in China. Information on maternal characteristics and selected neonatal outcomes was retrieved for all women who delivered singleton infants between 1 January 2009 and 31 December 2010.
RESULTS: A total of 21 947 singleton newborns and their mothers were included. The prevalence of maternal HBsAg positivity was 4.2% (95% confidence interval (CI) 3.9-4.5%). Compared with infants born to HBsAg-negative women, infants born to HBsAg-positive mothers were more than twice more likely to have a malformation before (adjusted odds ratio (aOR) 2.23, 95% CI 1.15-4.30) and at birth (aOR 2.66, 95% CI 1.38-5.14), but were less likely to be macrosomia (aOR 0.67, 95% CI 0.47-0.96). No statistically significant association was found between maternal HBsAg positivity and preterm birth (aOR 1.20, 95% CI 0.95-1.51), low birth weight (aOR 1.24, 95% CI 0.91-1.69), and Apgar scores at 1 min (aOR 0.88, 95% CI 0.49-1.57) and 5 min (aOR 1.84, 95% CI 0.89-3.81).
CONCLUSION: Maternal HBsAg positivity may be associated with a higher risk of congenital malformation.
METHODS: A retrospective cohort study was conducted using data from medical records database of six hospitals in China. Information on maternal characteristics and selected neonatal outcomes was retrieved for all women who delivered singleton infants between 1 January 2009 and 31 December 2010.
RESULTS: A total of 21 947 singleton newborns and their mothers were included. The prevalence of maternal HBsAg positivity was 4.2% (95% confidence interval (CI) 3.9-4.5%). Compared with infants born to HBsAg-negative women, infants born to HBsAg-positive mothers were more than twice more likely to have a malformation before (adjusted odds ratio (aOR) 2.23, 95% CI 1.15-4.30) and at birth (aOR 2.66, 95% CI 1.38-5.14), but were less likely to be macrosomia (aOR 0.67, 95% CI 0.47-0.96). No statistically significant association was found between maternal HBsAg positivity and preterm birth (aOR 1.20, 95% CI 0.95-1.51), low birth weight (aOR 1.24, 95% CI 0.91-1.69), and Apgar scores at 1 min (aOR 0.88, 95% CI 0.49-1.57) and 5 min (aOR 1.84, 95% CI 0.89-3.81).
CONCLUSION: Maternal HBsAg positivity may be associated with a higher risk of congenital malformation.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app